Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-15-001566
Filing Date
2015-02-25
Accepted
2015-02-25 11:29:04
Documents
1
Effectiveness Date
2015-02-25

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-15-001566.paper CERTNAS 294
  Scanned paper document scanned.pdf   35059
  Complete submission text file 9999999997-15-001566.txt   1327
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

EIN.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: CERTNAS | Act: 34 | File No.: 001-36856 | Film No.: 15005572
SIC: 2834 Pharmaceutical Preparations